Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Roser Torrá

ResearcherPublications, citations & collaboration network

Roser Torrá is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 318 works, 12,277 citations, an h-index of 57 and an i10-index of 156.

318
Works
12,277
Citations
57
h-index
156
i10-index

How has Roser Torrá's publication output changed over time?

ScholarIQpublication output · 1999–2022

Output grew0% over the shown period — from 1 works in 1999 to 1 in 2022.

1
1
2
1
2
2
1
1
19992008201120142015201620202022

What are the most-cited papers on Roser Torrá?

ScholarIQmost cited works
Unified Criteria for Ultrasonographic Diagnosis of ADPKD
York Pei, James Obaji, Annie Dupuis, Andrew D. Paterson, Riccardo Magistroni, Elizabeth Dicks, Patrick S. Parfrey, B. Cramer, Eliécer Coto, Roser Torrá, José L. San Millán, Robert N. Gibson, Martijn H. Breuning, Dorien J.M. Peters, David Ravine
Journal of the American Society of Nephrology. 2008755 CitationsOPEN ACCESS
Comparison of phenotypes of polycystic kidney disease types 1 and 2
Nick Hateboer, Marjan A. van Dijk, Nadja Bogdanova, Eliécer Coto, Anand K Saggar‐Malik, J L San Millán, Roser Torrá, Martijn H. Breuning, David Ravine
The Lancet. 1999626 Citations
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Arlene B. Chapman, Olivier Devuyst, Kai‐Uwe Eckardt, Ron T. Gansevoort, Tess Harris, Shigeo Horie, Bertram L. Kasiske, Dwight Odland, York Pei, Ronald D. Perrone, Yves Pirson, Robert W. Schrier, Roser Torrá, Vicente E. Torres, Terry Watnick, David C. Wheeler
Kidney International. 2015611 CitationsOPEN ACCESS
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
Dominique P. Germain, Derralynn Hughes, Kathy Nicholls, Daniel G. Bichet, Roberto Giugliani, William R. Wilcox, Claudio Feliciani, Suma P. Shankar, Fatih Süheyl Ezgü, Hernan Amartino, Drago Bratkovic, Ulla Feldt‐Rasmussen, Khan Nedd, Usama Sharaf El Din, Charles Marques Lourenço, Maryam Banikazemi, Joel Charrow, Majed Dasouki, David N. Finegold, Pilar Giraldo, Özlem Göker-Alpan, Nicola Longo, C. Ronald Scott, Roser Torrá, Ahmad Tuffaha, Ana Jovanović, Stephen Waldek, Seymour Packman, Elizabeth Ludington, Christopher Viereck, John Kirk, Julie Yu, Elfrida R. Benjamin, Franklin K. Johnson, David J. Lockhart, Nina Skuban, Jeff Castelli, Jay Barth, Carrolee Barlow, Raphael Schiffmann
New England Journal of Medicine. 2016560 CitationsOPEN ACCESS
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA
Alberto Ortíz, Mario Cozzolino, Danilo Fliser, Denis Fouque, Dimitrios Goumenos, Ziad A. Massy, Alexander R. Rosenkranz, Ivan Rychlík, María José Soler, Kate Stevens, Roser Torrá, Serhan Tuğlular, Christoph Wanner, Ron T. Gansevoort, ERACODA Working Group, Raphaël Duivenvoorden, Casper Franssen, Marc H. Hemmelder, Luuk B. Hilbrands, Kitty J. Jager, Marlies Noordzij, Priya Vart, Ron T Gansevoort
Nephrology Dialysis Transplantation. 2020378 CitationsOPEN ACCESS

Related on ScholarIQ

Universitat Autònoma de Barcelona
Institution
Unified Criteria for Ultrasonographic Diagnosis of ADPKD
Paper
Comparison of phenotypes of polycystic kidney disease types 1 and 2
Paper
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Paper
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
Paper
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA
Paper
470M+ articles · free account